العيش مع ويلسون مشروع يقوده المرضى

← العودة إلى جميع الإجابات

My Genetic Test for Wilson Disease Was Negative — Does That Rule It Out?

A negative genetic test does not definitively rule out Wilson disease; standard panels miss 5–20% of ATP7B mutations, so clinical testing (ceruloplasmin, urine copper, liver biopsy) remains essential.

A negative result on a genetic test sounds definitive. It isn’t — at least not for Wilson disease. If your genetic panel came back negative but your doctors or you still suspect Wilson disease based on symptoms or other test results, that suspicion should not be abandoned. Here is why, and what should happen next.

What a Genetic Test for Wilson Disease Actually Does

Wilson disease is caused by mutations in the ATP7B gene. Both copies of this gene — one from each parent — must be faulty for a person to have the disease. So far, researchers have identified more than 900 distinct mutations across the ATP7B gene.1

Most commercially available genetic panels test for a subset of known mutations, not the entire gene. The panel may be designed for a specific ethnic population (for example, the H1069Q mutation is common in Europeans; R778L is common in East Asians) or may only scan the most frequent variants globally.2 If you carry an unusual or population-specific mutation, or a mutation in a region of the gene the panel does not read, the test returns negative even though you do have Wilson disease.

Even when full gene sequencing is used — reading every base pair of ATP7B — the technique can still miss certain types of mutations: large deletions, intronic variants (mutations in non-coding regions), and duplications are harder to detect and are sometimes reported as negative or as variants of uncertain significance.3

How Often Do Genetic Tests Miss Wilson Disease?

The detection rate of genetic testing depends heavily on the method used:

Testing method Approximate detection rate
Targeted panel (common mutations only) 70–85% of confirmed cases
Full ATP7B gene sequencing 85–95% of confirmed cases
Full sequencing + deletion/duplication analysis ~97% in well-studied populations

Put another way: even a comprehensive test can miss Wilson disease in roughly 3–15% of people who actually have it. In a population with unusual or rare ATP7B variants, the miss rate is higher.12

This matters because Wilson disease is one of the few serious genetic diseases where the clinical tests are often more sensitive than the genetic test for initial diagnosis.

What the Clinical Tests Tell You That Genetics Cannot

The clinical workup for Wilson disease — serum ceruloplasmin, 24-hour urine copper, liver function tests, and slit-lamp examination for Kayser-Fleischer rings — measures what copper is actually doing in your body. These tests are imperfect too (ceruloplasmin has a false-negative rate of about 15% in symptomatic patients4), but together they assess the metabolic reality rather than just looking for a mutation.

The liver biopsy with quantitative copper measurement is the most direct test: if the hepatic copper concentration is elevated above the diagnostic threshold, that is strong evidence of Wilson disease regardless of what the genetic test shows.5 The Leipzig scoring system — a structured points-based diagnostic framework — specifically accounts for scenarios where genetic testing is ambiguous or negative, weighting clinical and biochemical findings heavily.5

If your genetic result is negative but your clinical results are borderline or concerning, the next step is not to accept the negative genetic test as final. It is to escalate the clinical workup. See all my tests are borderline for what that escalation looks like.

When a Negative Genetic Test Is More Reassuring

A negative genetic test is most meaningful when:

  1. Both parental mutations have already been identified — if your father and mother each have a known ATP7B mutation and you inherited neither, that is strong evidence you do not have Wilson disease.
  2. Family screening after a confirmed diagnosis — if a sibling has confirmed Wilson disease and full sequencing identified both mutations in that sibling, testing other siblings for those specific mutations is reliable.
  3. The clinical picture is convincingly non-Wilson — if ceruloplasmin is normal, urine copper is normal, Kayser-Fleischer rings are absent, and liver copper on biopsy is normal, then a negative genetic test fits a coherent picture.

Genetic testing is most useful to confirm a diagnosis in a family with known mutations, or to screen first-degree relatives once a proband’s mutations are known.3 It is less reliable as a standalone rule-out test in someone with unexplained symptoms.

What to Do Next If You Had a Negative Test

Ask your doctor or genetic counsellor these specific questions:

  • What method was used? (Targeted panel vs. full sequencing vs. sequencing plus deletion/duplication analysis)
  • What is the stated detection rate of this panel for Wilson disease?
  • Have clinical tests been done? If not, request serum ceruloplasmin, 24-hour urine copper, and a liver function panel.
  • Is referral to a metabolic disease specialist warranted? A hepatologist or geneticist with experience in copper metabolism disorders can interpret borderline or conflicting results more reliably than a general practitioner.

If full ATP7B sequencing has not been performed, it is reasonable to request it, particularly if the clinical suspicion remains. Some academic centres also offer research-grade sequencing or can access specialised laboratories.

A Note on Carrier Status

If only one copy of the ATP7B gene has a mutation — making you a carrier rather than someone with full Wilson disease — you will not develop the disease yourself, but your children could be at risk if they inherit a faulty copy from your partner as well. Carriers generally have no symptoms and no treatment is needed, though this is worth confirming with a specialist. See family screening for guidance on testing relatives.

The Bottom Line

A negative genetic test for Wilson disease is one data point, not a final verdict. The test’s limitations are well established in the literature, and the clinical workup — blood tests, urine tests, eye examination, and potentially liver biopsy — remains the standard of care for diagnosis when symptoms persist.6 If you or your child still has unexplained symptoms after a negative genetic test, pursue the full clinical evaluation before concluding Wilson disease has been ruled out.

This article is patient education, not medical advice. Interpreting genetic test results in the context of Wilson disease requires specialist input — the same laboratory finding can mean very different things depending on which method was used and what your clinical picture shows. Talk to your hepatologist, neurologist, or genetic counsellor.

References


  1. Ferenci, Peter. “Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing.” Human Genetics 120, no. 2 (2006): 151–159. https://doi.org/10.1007/s00439-006-0202-5. 

  2. Czlonkowska, Anna, Michael Litwin, Piotr Chabik, et al. “Wilson disease.” Nature Reviews Disease Primers 4, no. 1 (2018): 22. https://doi.org/10.1038/s41572-018-0024-5. 

  3. Schilsky, Michael L., Eve A. Roberts, Jeff M. Bronstein, et al. “A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases.” Hepatology 82, no. 3 (2022): E41–E90. https://doi.org/10.1002/hep.32801. 

  4. Mak, Chloe M., Ching-Wan Lam, and Sidney Tam. “Diagnostic Accuracy of Serum Ceruloplasmin in Wilson Disease: Determination of Sensitivity and Specificity by ROC Curve Analysis among ATP7B-Genotyped Subjects.” Clinical Chemistry 54, no. 8 (2008): 1356–1362. https://doi.org/10.1373/clinchem.2008.103432. 

  5. Nicastro, Emanuele, Giusy Ranucci, Pietro Vajro, Angela Vegnente, and Raffaele Iorio. “Re-evaluation of the Diagnostic Criteria for Wilson Disease in Children With Mild Liver Disease.” Hepatology 52, no. 6 (2010): 1948–1956. https://doi.org/10.1002/hep.23910. 

  6. European Association for the Study of the Liver. “EASL Clinical Practice Guidelines: Wilson’s disease.” Journal of Hepatology 56, no. 3 (2012): 671–685. https://doi.org/10.1016/j.jhep.2011.11.007. 

  7. Alkhouri, Naim, Regino P. Gonzalez-Peralt, and Valentina Medici. “Wilson disease: a summary of the updated AASLD Practice Guidance.” Hepatology Communications 7, no. 6 (2023). https://doi.org/10.1097/HC9.0000000000000150. 

هذا تثقيف للمرضى وليس نصيحة طبية. استشر فريقك الطبي دائمًا بشأن القرارات المتعلقة برعايتك.